8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2015 / Randomized crossover trial
A randomized crossover trial in 22 patients with type 2 diabetes evaluated test days with or without breakfast. Skipping breakfast increased 0-180 minute lunch area under the curve for glucose by 36.8%, free fatty acids by 41.1%, and glucagon by 14.8%, while lowering insulin by 17% and intact GLP-1 by 19% (P < 0.0001). Similar worsening of glucose, fatty acids, glucagon, insulin, and GLP-1 occurred after dinner.
Jakubowicz D, Wainstein J, Ahren B, et al. Diabetes Care, 2015. PMID 26220945
2015 / Randomized crossover trial
In a randomized crossover trial, 12 adults with metabolic syndrome consumed three test meals matched for fiber or antioxidant capacity on three occasions with five hours of postprandial monitoring. Insulin was lower after the black bean meal versus the matched meals (p < 0.0001). Plasma antioxidant capacity differed over time (p = 0.002), oxidized LDL showed no difference by meal, and triglycerides and interleukin-6 rose after meals (p < 0.0001).
Reverri EJ, Randolph JM, Steinberg FM, et al. Nutrients, 2015. PMID 26225995
2015 / Randomized, open-label, parallel-arm trial with blinded endpoints
In an 86-patient randomized trial, participants completed a 4-week run-in on atorvastatin 10 mg, followed by 4 weeks on atorvastatin 40 mg, ezetimibe 10 mg, or both. In the next 4-week phase, 2.0 g of plant sterols were added to these treatments. Adding plant sterols further reduced total and LDL cholesterol by ~7.7% and 6.5%, respectively, in the atorvastatin group, and by 5.0% and 4.0% in the combination therapy group (P < .05 for all). Plant sterol supplementation produced no additional effects on markers of cholesterol absorption or synthesis.
Malina DM, Fonseca FA, Barbosa SA, et al. J Clin Lipidol, 2015. PMID 26228672
2015 / Randomized double-blind, placebo-controlled trial
A randomized, double-blind, placebo-controlled trial investigated the effect of 12 weeks of onion peel extract (OPE; 100 mg quercetin/d, n=36) versus placebo (n=36) in healthy overweight and obese individuals. Compared with baseline, the OPE group experienced a significant increase in flow-mediated dilation (from 12.5 ± 5.2 to 15.2 ± 6.1; P = 0.002), while the placebo group saw no change. Additionally, EPC counts increased significantly in the OPE group (from 44.2 ± 25.6 to 52.3 ± 18.6; P = 0.005), and the rate of participants in the lowest FMD quartile dropped from 26% to 9%.
Choi EY, Lee H, Woo JS, et al. Nutrition, 2015. PMID 26233871
2015 / Pre-post acute intervention study
Researchers evaluated the acute effects of polyphenols from an aqueous Hibiscus sabdariffa extract in healthy male volunteers by comparing transcriptomic and metabolomic data before and 3 hours after ingestion. The intervention suggested roles in mitochondrial function, energy homeostasis, cardiovascular protection, and inhibition of the renin-angiotensin system and angiotensin-converting enzyme. Serum analysis revealed a decrease in cortisol levels and a significant increase in the active vasodilator metabolite des-Arg(9)-bradykinin.
Beltrán-Debón R, Rodríguez-Gallego E, Fernández-Arroyo S, et al. Food Funct, 2015. PMID 26234931
2015 / Randomized controlled trial
Seventy-five patients meeting Rome III criteria for irritable bowel syndrome were randomized to a low-FODMAP diet (n = 38) or traditional dietary advice (n = 37) for four weeks. Symptom severity decreased significantly in both groups (p < 0.0001), with no significant difference between treatments (p = 0.62). Reductions in severity scores of 50 or more occurred in 50% of the low-FODMAP group and 46% of the traditional diet group.
Böhn L, Störsrud S, Liljebo T, et al. Gastroenterology, 2015. PMID 26255043
2015 / Randomized crossover trial
Twenty middle-aged participants consumed either a barley kernel-based bread (BB) or a reference white wheat bread for 3 consecutive days in a randomized crossover design, followed by a standardized breakfast on day 4. Compared to reference bread, 3 days of BB increased fasting plasma GLP-1 by 56%, postprandial plasma GLP-2 by 13%, and postprandial plasma PYY by 18%. BB intervention also increased breath H2 excretion by 363% and fasting serum SCFAs by 18%, while decreasing blood glucose responses by 22% and serum insulin responses by 17%. Insulin sensitivity index (ISIcomposite) was improved by 25% following the BB intervention.
Nilsson AC, Johansson-Boll EV, Björck IM Br J Nutr, 2015. PMID 26259632
2015 / Intervention trial (pre-post dietary challenge)
Following a 2-week eucaloric control diet, 10 nonobese men consumed a eucaloric high-fat diet (55% fat) for 5 days. Fasting plasma TMAO did not increase significantly after the diet (1.83 ± 0.21 vs 1.6 ± 0.24 μmol/L). However, postprandial plasma TMAO was significantly higher across 4 hours following a high-fat meal challenge compared with baseline: hour 1 (2.15 ± 0.28 vs 1.7 ± 0.30 μmol/L), hour 2 (2.3 ± 0.29 vs 1.8 ± 0.32 μmol/L), hour 3 (2.4 ± 0.34 vs 1.58 ± 0.19 μmol/L), and hour 4 (2.51 ± 0.33 vs 1.5 ± 0.12 μmol/L; all P < .05).
Boutagy NE, Neilson AP, Osterberg KL, et al. Nutr Res, 2015. PMID 26265295
2015 / Randomized controlled trial
In a randomized controlled trial, 150 coronary artery disease patients with low baseline HDL cholesterol were assigned to receive 10 g/d of Pakistani almonds, 10 g/d of American almonds, or no intervention for 12 weeks. At weeks 6 and 12, HDL cholesterol was 12-14% and 14-16% higher than baseline, respectively, in both almond groups. Both almond groups also had significant reductions compared to baseline in total cholesterol, triglycerides, LDL cholesterol, VLDL cholesterol, total-to-HDL and LDL-to-HDL ratios, and the atherogenic index (P < 0.05), with no differences between almond varieties. Dietary patterns, body weight, and blood pressure did not change in any group.
Jamshed H, Sultan FA, Iqbal R, et al. J Nutr, 2015. PMID 26269239
2015 / Randomized crossover metabolic ward trial
In a metabolic ward, 19 adults with obesity consumed isocaloric diets selectively restricting carbohydrate versus fat for 6 days following a 5-day baseline diet, in random order across two inpatient stays with daily exercise. Body fat loss was calculated from fat intake and net fat oxidation measured in a metabolic chamber. Carbohydrate restriction increased fat oxidation and led to a loss of 53 ± 6 g/day of body fat, whereas fat restriction resulted in 89 ± 6 g/day of fat loss, which was significantly greater (p = 0.002). Mathematical model simulations predicted that the body acts to minimize body fat differences over prolonged periods.
Hall KD, Bemis T, Brychta R, et al. Cell Metab, 2015. PMID 26278052
2015 / Randomized controlled trial
In a randomized trial of 102 healthy non-smoking adults aged 48 to 76 years, consuming 1 kg weekly of fish and mussels for 26 weeks significantly increased whole-blood trace element concentrations compared with controls eating under 300 g weekly. Differences in mean change between groups were 5.1 ng/ml (95% CI: 4.4, 5.8) for mercury, 7.1 ng/ml (95% CI: 5.0, 9.2) for arsenic, and 2.6 ng/ml (95% CI: 0.0, 5.2) for lead.
Outzen M, Tjønneland A, Larsen EH, et al. Food Addit Contam Part A Chem Anal Control Expo Risk Assess, 2015. PMID 26284299
2015 / Randomized controlled trial
Twenty-eight recreational runners were randomized to receive purple grape juice at 10 mL/(kg·min) or an isocaloric, isovolumetric control beverage for 28 days. Grape juice increased running time to exhaustion by 15.3% (p = 0.002) and boosted total antioxidant capacity by 38.7% (p = 0.009). It did not alter aerobic capacity or anaerobic threshold, and no significant changes occurred in the control group.
Toscano LT, Tavares RL, Toscano LT, et al. Appl Physiol Nutr Metab, 2015. PMID 26288392
2015 / Randomized controlled trial
In an ancillary trial within AREDS2, 3,501 older adults at risk for late age-related macular degeneration were randomized to receive omega-3 polyunsaturated fatty acids, lutein/zeaxanthin, both, or placebo. Over five years, yearly change in composite cognitive test scores did not differ between the fatty acid group (-0.19; 99% CI, -0.25 to -0.13) and control (-0.18; 99% CI, -0.24 to -0.12; P = .63). Similarly, lutein/zeaxanthin showed no difference compared to placebo (P = .66).
Chew EY, Clemons TE, Agrón E, et al. JAMA, 2015. PMID 26305649
2015 / Randomized controlled trial
A 12-week randomized trial assigned 458 Bangladeshi adults to placebo, 3 g/d creatine, 400 μg/d folic acid, or creatine plus folic acid. Creatine decreased plasma guanidinoacetate by 10.6% (95% CI: 4.9, 15.9) compared to placebo and by 9.0% (95% CI: 3.4, 14.2) with folic acid versus folic acid alone. However, creatine did not significantly change plasma total homocysteine compared to controls.
Peters BA, Hall MN, Liu X, et al. J Nutr, 2015. PMID 26311810
2015 / Randomized crossover trial
A two-part randomized double-blind crossover study in 10 overweight men examined acute glucose and insulin responses over 2 hours following 50 g glucose with instant decaffeinated coffee and caffeine. Varying caffeine alongside decaffeinated coffee elevated postprandial glucose responses (P=0.008), with 2 g and 4 g coffee increasing glycemic excursions. Escalating coffee amounts with fixed 100 mg caffeine showed no effect.
Robertson TM, Clifford MN, Penson S, et al. Br J Nutr, 2015. PMID 26316273
2015 / Randomized crossover trial
In a randomized crossover trial, 28 glucose-tolerant and 27 impaired-glucose-tolerant individuals consumed 50 g carbohydrate daily from honey, sucrose, or HFCS55 for 2 weeks each, separated by 2- to 4-week washout periods. Glucose, insulin, HOMA-IR, and OGTT iAUC for glucose or insulin did not differ by sweetener treatment. Across all treatments, body weight and systolic blood pressure were unchanged, diastolic blood pressure decreased, and triglyceride concentrations increased significantly. In the impaired glucose tolerance group, high-sensitivity C-reactive protein increased in response to all sugars.
Raatz SK, Johnson LK, Picklo MJ J Nutr, 2015. PMID 26338891
2015 / Randomised, double-blind, placebo-controlled, parallel-groups study
In a randomised, double-blind, placebo-controlled study, 60 adults aged 18 to 30 years were given resveratrol or placebo for 28 days. Resveratrol modulated cerebral blood flow (CBF) parameters on day 1 as assessed by near-IR spectroscopy and significantly lowered subjective ratings of fatigue across the entire 28 days. Cognitive effects were limited to more accurate but slower serial subtraction performance on day 1, and improved 3-Back task accuracy before dose on day 28. Resveratrol significantly increased diastolic blood pressure on day 28 and resulted in higher resveratrol metabolite levels on day 28 compared with day 1.
Wightman EL, Haskell-Ramsay CF, Reay JL, et al. Br J Nutr, 2015. PMID 26344014
2015 / Double-blind randomized crossover study
Twenty healthy volunteers randomly received an acid-resistant capsule containing either placebo or 18 mg of hydrochloride (HCl) quinine on 2 separate days, followed by an ad libitum meal 60 minutes later. Calorie intake was significantly lower with quinine compared to placebo (514 ± 248 vs 596 ± 286 kcal; P = 0.007). Higher CCK ΔT90 vs T0 and ΔT90 vs T60 were observed with quinine versus placebo (0.70 ± 0.69 vs 0.10 ± 0.86 ng/mL, P = 0.026; 0.92 ± 0.75 vs 0.50 ± 0.55 ng/mL, P = 0.033). The calorie reduction was significant in PTC tasters (526 ± 275 vs 659 ± 320 kcal; P = 0.005) but not in PTC non-tasters (499 ± 227 vs 519 ± 231 kcal; P = 0.525).
Andreozzi P, Sarnelli G, Pesce M, et al. J Neurogastroenterol Motil, 2015. PMID 26351252
2015 / Randomized, double-blind, placebo-controlled trial
In a randomized trial, 42 high school students received either 500 mg per day of vitamin C or a placebo for 14 days. Supplementation significantly decreased anxiety levels on the Beck Anxiety Inventory and increased plasma vitamin C concentrations compared to placebo. A significant difference in mean heart rate was also observed between groups.
de Oliveira IJ, de Souza VV, Motta V, et al. Pak J Biol Sci, 2015. PMID 26353411
2015 / Randomized controlled trial
Twenty-four elderly patients diagnosed with depression were randomly divided into an experimental group practicing Nordic walking and a control group practicing normal walking. Both groups exercised for 50 minutes per day, three times per week for eight weeks. Both groups showed significant improvements in depression over time, with significant differences over time between groups for depression, sleep, and skeletal muscle mass.
Park SD, Yu SH J Phys Ther Sci, 2015. PMID 26357429
2015 / Randomized, double-blind, placebo-controlled phase 2 trial
In a 52-week phase 2 trial, 119 participants with mild to moderate Alzheimer disease were randomized to placebo or oral resveratrol (dose-escalated from 500 mg daily to 1,000 mg twice daily). Resveratrol and its major metabolites penetrated the blood-brain barrier. The most frequent adverse events were nausea, diarrhea, and weight loss. CSF Aβ40 and plasma Aβ40 levels declined more in the placebo group than in the resveratrol group, producing a significant difference at week 52, while brain volume loss was increased with resveratrol compared to placebo.
Turner RS, Thomas RG, Craft S, et al. Neurology, 2015. PMID 26362286
2015 / Randomized controlled trial
A pilot study investigated the acute DNA-protective effect of a single dose of American ginseng tea bag infusion. Fourteen healthy subjects were divided into an intervention group of 7 drinking American ginseng infusion and a control group of 7 drinking water. Blood samples collected before and 2 hours post-ingestion were challenged with ultraviolet B irradiation and analyzed via comet assay. Results showed a significant decrease in comet score after American ginseng supplementation, with no change observed in the control group.
Szeto YT, Sin YS, Pak SC, et al. Int J Food Sci Nutr, 2015. PMID 26393910
2015 / Randomized, double-blind, placebo-controlled trial
In a 2-year trial, older women aged 70-80 years were assigned to a daily drink containing either 30 g whey protein (n = 109) or 2.1 g protein placebo (n = 110). A mean increase of ~20 g/d protein was confirmed in the protein group via 24-hour urinary nitrogen. Over 2 years, both groups experienced significant declines in upper arm muscle area (-5.59 ± 0.75 cm²), calf muscle area (-0.77 ± 0.11 cm²), and hand grip strength (-1.30 ± 0.3 kg) (all P < 0.05). However, there were no significant effects of protein supplementation on any muscle mass or physical function measures at 1 and 2 years (all P > 0.05).
Zhu K, Kerr DA, Meng X, et al. J Nutr, 2015. PMID 26400966
2015 / Observational cohort with a 16-week intervention sub-study
Using a smartphone app, researchers tracked ingestion events in non-shift-working healthy adults. Half of the cohort had a daily intake duration exceeding 14.75 hours, with <25% of calories consumed before noon and >35% after 6 p.m. When overweight individuals with baseline eating durations >14 hours restricted intake to 10-11 hours daily for 16 weeks, they reduced body weight, reported feeling energetic, and improved sleep, with benefits persisting for a year.
Gill S, Panda S Cell Metab, 2015. PMID 26411343